Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nianchun Shan, Wei Zhou, Shufen Zhang & Yu Zhang. (2016) Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis. OncoTargets and Therapy 9, pages 2169-2179.
Read now
Read now
F. Guidozzi. (2016) Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation. Climacteric 19:5, pages 419-422.
Read now
Read now
Articles from other publishers (31)
Johanna Loris, Lena Hanesch, Gerd Bauerschmitz, Julia Gallwas & Carsten Gründker. (2023) Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells. International Journal of Molecular Sciences 24:18, pages 13705.
Crossref
Crossref
Jennifer M. McCracken, Gisele A. Calderon, Quynh N. Le, Natasha M. Faruqui, Swathi Balaji & Julie C. E. Hakim. (2023) Cellular and extracellular vaginal changes following murine ovarian removal. Physiological Reports 11:15.
Crossref
Crossref
Susanne Schüler-Toprak & Olaf Ortmann. (2022) Vaginale ÖstrogentherapieVaginal estrogen therapy. Gynäkologische Endokrinologie 20:3, pages 197-200.
Crossref
Crossref
Matthias Läsche, Julia Gallwas & Carsten Gründker. (2022) Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer. International Journal of Molecular Sciences 23:9, pages 5050.
Crossref
Crossref
Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, Kuldeep Dhama, M. Yasmin Begum, Afaf Aldahish, Kumarappan Chidambaram & Talha Bin Emran. (2022) Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?. Cancers 14:3, pages 759.
Crossref
Crossref
Eshwarya Jessy Kaur, Upasana Baruah, Amita Maheshwari & Amal Chandra Kataki. 2022. Fundamentals in Gynaecologic Malignancy. Fundamentals in Gynaecologic Malignancy
429
438
.
Neha MishraNilanchali SinghMohini SachdevaPrafull Ghatage. (2021) Sexual Dysfunction in Cervical Cancer Survivors: A Scoping Review. Women's Health Reports 2:1, pages 594-607.
Crossref
Crossref
Saara Bryk, Sushmita Katuwal, Ulla-Maija Haltia, Johanna Tapper, Juha S. Tapanainen & Eero Pukkala. (2021) Parity, menopausal hormone therapy, and risk of ovarian granulosa cell tumor – A population-based case-control study. Gynecologic Oncology 163:3, pages 593-597.
Crossref
Crossref
Christoph Uleer, Edward Wight & Clemens Tempfer. (2021) Nachsorge des EndometriumkarzinomsAftercare of endometrial cancer. Der Gynäkologe 54:2, pages 83-88.
Crossref
Crossref
Hasan Çilgin. 2020. Hormone Therapy and Replacement in Cancer and Aging-related Diseases. Hormone Therapy and Replacement in Cancer and Aging-related Diseases.
Claire D. James, Iain M. Morgan & Molly L. Bristol. (2020) The Relationship between Estrogen-Related Signaling and Human Papillomavirus Positive Cancers. Pathogens 9:5, pages 403.
Crossref
Crossref
Ulla-Maija Haltia, Marjut Pihlajoki, Noora Andersson, Lotta Mäkinen, Johanna Tapper, Alejandra Cervera, Hugo M Horlings, Ursula Turpeinen, Mikko Anttonen, Ralf Bützow, Leila Unkila-Kallio, Olli Carpén, David B Wilson, Markku Heikinheimo & Anniina Färkkilä. (2020) Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors. Journal of the Endocrine Society 4:4.
Crossref
Crossref
Katie K. Crean-Tate, Stephanie S. Faubion, Holly J. Pederson, Jennifer A. Vencill & Pelin Batur. (2020) Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy. American Journal of Obstetrics and Gynecology 222:2, pages 103-113.
Crossref
Crossref
Nungrutai Saeaib, Krantarat Peeyananjarassri, Tippawan Liabsuetrakul, Rakchai Buhachat & Eva Myriokefalitaki. (2020) Hormone replacement therapy after surgery for epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2020:1.
Crossref
Crossref
Benjamin S. Harris, Katherine C. Bishop, Jeffrey A. Kuller, Anne C. Ford, Lisa C. Muasher, Sarah E. Cantrell & Thomas M. Price. (2020) Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. Menopause 27:2, pages 243-248.
Crossref
Crossref
Tamás Deli, Mónika Orosz & Attila Jakab. (2019) Hormone Replacement Therapy in Cancer Survivors – Review of the Literature. Pathology & Oncology Research 26:1, pages 63-78.
Crossref
Crossref
Prashant Purohit, Jennifer Sassarini & Mary Ann Lumsden. (2019) Management of Induced Menopause in Gynaecological Cancers and Their Challenges. Current Obstetrics and Gynecology Reports 8:3, pages 94-102.
Crossref
Crossref
Hyun-Woong Cho, Yung-Taek Ouh, Jae Kwan Lee & Jin Hwa Hong. (2019) Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database. Journal of Gynecologic Oncology 30:4.
Crossref
Crossref
Shirin Khanjani & Nick Panay. (2019) Vaginal estrogen deficiency. The Obstetrician & Gynaecologist 21:1, pages 37-42.
Crossref
Crossref
Marie Smith, Lorna Lightbody, Ali Allen & Michelle Winser. 2019. Nursing Management of Women’s Health. Nursing Management of Women’s Health
169
192
.
. (2018) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 25:11, pages 1362-1387.
Crossref
Crossref
Ladan Yeganeh, Cheryce Harrison, Amanda J. Vincent, Helena Teede & Jacqueline A. Boyle. (2018) Effects of lifestyle modification on cancer recurrence, overall survival and quality of life in gynaecological cancer survivors: A systematic review and meta-analysis. Maturitas 111, pages 82-89.
Crossref
Crossref
Roberto Angioli, Daniela Luvero, Grazia Armento, Stella Capriglione, Francesco Plotti, Giuseppe Scaletta, Salvatore Lopez, Roberto Montera, Alessandra Gatti, Giovan Battista Serra, Pierluigi Benedetti Panici & Corrado Terranova. (2018) Hormone replacement therapy in cancer survivors: Utopia?. Critical Reviews in Oncology/Hematology 124, pages 51-60.
Crossref
Crossref
. (2017) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24:7, pages 728-753.
Crossref
Crossref
Susanne Schüler-Toprak, Stephan Seitz & Olaf Ortmann. (2017) Hormones and risk of breast and gynecological cancerHormone und das Risiko für Brustkrebs und gynäkologische Malignome. Der Gynäkologe 50:1, pages 43-54.
Crossref
Crossref
John Durfee. 2017. Essentials of Menopause Management. Essentials of Menopause Management
273
284
.
Stella Capriglione, Francesco Plotti, Roberto Montera, Daniela Luvero, Salvatore Lopez, Giuseppe Scaletta, Alessia Aloisi, Giovan Battista Serra & Roberto Angioli. (2016) Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial. Gynecologic Oncology 143:3, pages 584-588.
Crossref
Crossref
Stephanie S. FaubionKathy L. MacLaughlinMargaret E. LongSandhya PruthiPetra M. Casey. (2015) Surveillance and Care of the Gynecologic Cancer Survivor. Journal of Women's Health 24:11, pages 899-906.
Crossref
Crossref
Nicoletta Biglia, Valentina Elisabetta Bounous, Luca Giuseppe Sgro, Marta D’Alonzo & Martina Gallo. (2015) Treatment of climacteric symptoms in survivors of gynaecological cancer. Maturitas 82:3, pages 296-298.
Crossref
Crossref
Franco Guidozzi. 2015. Managing the Menopause. Managing the Menopause
173
182
.
Anna Myriam Perrone. (2014) Gynecological malignancies and hormonal therapies: Clinical management and recommendations. World Journal of Obstetrics and Gynecology 3:4, pages 162.
Crossref
Crossref